evidenceId,evidenceType,shortDesc,desc,id,lastEdit,status,gene/entrezGeneId,gene/hugoSymbol,gene/name,gene/oncogene,gene/curatedIsoform,gene/curatedRefSeq,gene/geneAliases/0,gene/geneAliases/1,gene/geneAliases/2,gene/geneAliases/3,gene/geneAliases/4,gene/tsg,articles/0/pmid,articles/0/title,articles/0/journal,articles/0/pubDate,articles/0/volume,articles/0/issue,articles/0/pages,articles/0/authors,articles/0/elocationId,articles/0/link,articles/0/reference,articles/0/abstract,articles/1/pmid,articles/1/title,articles/1/journal,articles/1/pubDate,articles/1/volume,articles/1/issue,articles/1/pages,articles/1/authors,articles/1/elocationId,articles/1/link,articles/1/reference,articles/1/abstract,articles/2/pmid,articles/2/title,articles/2/journal,articles/2/pubDate,articles/2/volume,articles/2/issue,articles/2/pages,articles/2/authors,articles/2/elocationId,articles/2/link,articles/2/reference,articles/2/abstract,articles/3/pmid,articles/3/title,articles/3/journal,articles/3/pubDate,articles/3/volume,articles/3/issue,articles/3/pages,articles/3/authors,articles/3/elocationId,articles/3/link,articles/3/reference,articles/3/abstract,articles/4/pmid,articles/4/title,articles/4/journal,articles/4/pubDate,articles/4/volume,articles/4/issue,articles/4/pages,articles/4/authors,articles/4/elocationId,articles/4/link,articles/4/reference,articles/4/abstract,articles/5/pmid,articles/5/title,articles/5/journal,articles/5/pubDate,articles/5/volume,articles/5/issue,articles/5/pages,articles/5/authors,articles/5/elocationId,articles/5/link,articles/5/reference,articles/5/abstract,articles/6/pmid,articles/6/title,articles/6/journal,articles/6/pubDate,articles/6/volume,articles/6/issue,articles/6/pages,articles/6/authors,articles/6/elocationId,articles/6/link,articles/6/reference,articles/6/abstract,articles/7/pmid,articles/7/title,articles/7/journal,articles/7/pubDate,articles/7/volume,articles/7/issue,articles/7/pages,articles/7/authors,articles/7/elocationId,articles/7/link,articles/7/reference,articles/7/abstract
6361,GENE_SUMMARY,,"AKT2, an intracellular kinase, is amplified at low frequencies in a diverse range of cancers.",,2017-10-23,,208,AKT2,AKT serine/threonine kinase 2,True,ENST00000392038,NM_001626.4,HIHGHH,PRKBB,PKBBETA,RAC-BETA,PKBB,False,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
6362,GENE_BACKGROUND,,"The AKT2 protein is a serine/threonine protein kinase that is a critical downstream effector in the PI3K signaling pathway. AKT2, along with closely related AKT1 and AKT3, are members of the AGC kinase family. Effects of AKT activation include cell cycle progression and increased migration, differentiation and glucose homeostasis (PMID: 12094235). AKT2 activation occurs when its pleckstrin homology domain (PHD) dislodges from the kinase domain (KD), localizes to the cell membrane, and several of its key residues become phosphorylated (PMID: 9374542). AKT2 is an oncogene that is activated in numerous cancers, mostly through amplification of the 19q13.1-q13.2 chromosomal region (PMID: 1409633, 9496907) or overexpression (PMID: 11756242), which promote invasion and metastasis (PMID: 12517798). Germline autosomal dominant mutations in AKT2 are associated with familial diabetes mellitus in humans (PMID: 15166380). There are numerous drugs that target the PI3K/AKT pathway, including inhibitors of AKT itself, and inhibitors of PI3K and mTOR (PMID: 19629070).",,2017-10-11,,208,AKT2,AKT serine/threonine kinase 2,True,ENST00000392038,NM_001626.4,HIHGHH,PRKBB,PKBBETA,RAC-BETA,PKBB,False,15166380,A family with severe insulin resistance and diabetes due to a mutation in AKT2.,"Science (New York, N.Y.)",2018-05-28T20:04:00,304,5675,1325-8,George S et al,,,0001-05-28,,1409633,"AKT2, a putative oncogene encoding a member of a subfamily of protein-serine/threonine kinases, is amplified in human ovarian carcinomas.",Proceedings of the National Academy of Sciences of the United States of America,0001-10-01,89,19,9267-71,Cheng JQ et al,,,0001-10-01,,11756242,AKT proto-oncogene overexpression is an early event during sporadic colon carcinogenesis.,Carcinogenesis,2018-01-01T20:02:00,23,True,201-5,Roy HK et al,,,0001-01-01,,19629070,"Targeting PI3K signalling in cancer: opportunities, challenges and limitations.",Nature reviews. Cancer,2018-08-01T20:09:00,9,8,550-62,Engelman JA,doi: 10.1038/nrc2664,,0001-08-01,,9496907,Amplification and overexpression of the AKT2 oncogene in a subset of human pancreatic ductal adenocarcinomas.,Molecular carcinogenesis,0001-02-01,21,2,1981-06-01,Ruggeri BA et al,,,0001-02-01,,9374542,"Mitogenic activation, phosphorylation, and nuclear translocation of protein kinase Bbeta.",The Journal of biological chemistry,0001-11-28,272,48,30491-7,Meier R et al,,,0001-11-28,,12094235,The phosphatidylinositol 3-Kinase AKT pathway in human cancer.,Nature reviews. Cancer,2018-07-01T20:02:00,2,7,489-501,Vivanco I et al,,,2018-07-01T05:01:00,,12517798,"Overexpression of AKT2/protein kinase Bbeta leads to up-regulation of beta1 integrins, increased invasion, and metastasis of human breast and ovarian cancer cells.",Cancer research,2018-01-01T20:03:00,63,True,196-206,Arboleda MJ et al,,,2018-01-01T02:06:00,
